ArticleTanaffos2024
Thoracoplasty: A Collapse Therapy for Extra-Pulmonary Drug-Resistant Tuberculosis with Persistent Bronchopleural Fistula and Empyema Cavity.
Article in Tanaffos, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The role of thoracoplasty in modern thoracic surgery: a narrative review with three illustrative cases.Journal of thoracic disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Multi-drug-resistant tuberculosis (MDR-TB) has become a significant health problem worldwide. As per the Global Tuberculosis Report 2021, chemotherapy has only benefitted 59% of individuals. As many patients do not benefit from radical surgery due to their poor pulmonary reserve, bacterial overload, and prognosis, collapse therapy has an essential role in improving the effectiveness of complex anti-tubercular therapy. Case Presentation: A 35-year-old male with a low body mass index and persistent air leak on an intercostal tube not responding to medical management underwent thoracoscopic decortication. He was diagnosed with multi-drug-resistant tuberculosis (MDR-TB) according to the pleural specimen. Postoperatively, the lung did not seem to expand due to the extensive disease, and the air leak persisted. Hence, he received a short-term MDR-TB regimen and underwent open window thoracostomy followed by limited thoracoplasty for postoperative persistent infected pleural space. Conclusion: Though pleural MDR-TB is a rare presentation, managing the infected pleural space is challenging as patients tend to have significant morbidity due to various factors.
Indexed as
Identifiers
40704348PMC12281340What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.